Combined therapy group:None

2 trials

Sponsors

The Third Medical Centre, Chinese PLA General Hospital, Beijing, China, Eye Hospital, Wenzhou Medical University

Conditions

Meibomian gland dysfunctionRenal cell carcinoma

Unknown Phase

An observational clinical study on the efficacy of preoperative targeted therapy combined immunotherapy in advanced renal cell carcinoma

RecruitingChiCTR2400091799

The Third Medical Centre, Chinese PLA General Hospital, Beijing, ChinaRenal cell carcinoma

Start: 2024-11-11Updated: 2024-11-11

Study on the Classification and Efficacy of Meibomian Gland Dysfunction Based on Unsupervised Learning in Radiomics

Active, not recruitingChiCTR2500112870

Eye Hospital, Wenzhou Medical UniversityMeibomian gland dysfunction

Start: 2025-12-01Updated: 2025-11-24